Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
Anaesthesia|August 1, 1986
The work of the Leeds Malignant Hyperpyrexia Unit, 1971-84F R Ellis, P J Halsall, D G HarrimanBritish Journal of Anaesthesia|January 1, 1988
Malignant hyperpyrexia and sudden infant death syndromeF R Ellis, P J Halsall, D G HarrimanBritish Journal of Anaesthesia|April 1, 1984
Suxamethonium spasm. A differential diagnostic conundrumF R Ellis, P J HalsallBritish Journal of Anaesthesia|February 1, 1992
Does postoperative pyrexia indicate malignant hyperthermia susceptibility?P J Halsall, F R EllisBritish Journal of Anaesthesia|August 1, 1979
A screening test for the malignant hyperpyrexia phenotype using suxamethonium-induced contracture of muscle treated with caffeine and its inhibition by dantroleneP J Halsall, F R EllisActa Anaesthesiologica Scandinavica|June 1, 1983
The control of muscle contracture by the action of dantrolene on the sarcolemmaP J Halsall, F R EllisBritish Journal of Anaesthesia|April 1, 1993
Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disordersP M Hopkins, F R Ellis, P J HalsallBritish Journal of Anaesthesia|November 1, 1992
Evaluation of spin resonance spectroscopy of red blood cell membranes to detect malignant hyperthermia susceptibilityP J Halsall, F R Ellis, P F KnowlesAnaesthesia|October 1, 1990
Clinical presentation of suspected malignant hyperthermia during anaesthesia in 402 probandsF R Ellis, P J Halsall, A S ChristianBritish Journal of Anaesthesia|May 1, 1991
Ryanodine contracture: a potentially specific in vitro diagnostic test for malignant hyperthermiaP M Hopkins, F R Ellis, P J HalsallPageof 10